GLP-1 medications provide significant heart protection by reducing inflammation, improving cholesterol profiles, and lowering the risk of heart failure and stroke
In 2025, Ozempic was approved by the US Food and Drug Administration (FDA) to reduce the risk of worsening kidney disease and kidney failure in people with type 2 diabetes
We describe prescribing volumes and patient characteristics over time, by medication, and by FDA-labeled use (e.g., ADM, AOM, or unknown)
If you have clinical hypothyroidism (elevated TSH and low thyroid hormone levels), treatment is thyroid hormone replacement with levothyroxine (see Thyroid Hormone Treatment brochure )
Heymsfield SB, Coleman LA, Miller R, Rooks DS, Laurent D, Petricoul O, et al
Safe, practical peptide picks Which peptides are approachable, and why do you favor oral forms